PICTON MAHONEY ASSET MANAGEMENT

Position in ABBV — AbbVie Inc.

CIK 1539041 Toronto, A6

Position in ABBV

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$6,416,065

-$7,221,427 QoQ

Shares Held

25,497

-59.3% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.06%

of 13F equity value

Holder Rank

#1,164

of 4,153 holders

Holding Since

Mar 2022

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

PICTON MAHONEY ASSET MANAGEMENT holds $130,004,533 across 10 Drug Manufacturers - General names. ABBV ranks #7 (4.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	33,628	$40,334,435
2	JNJ	Johnson & Johnson	96,594	$24,531,978
3	MRK	Merck & Co., Inc.	176,844	$22,724,454
4	GILD	Gilead Sciences, Inc.	119,118	$15,049,368
5	BIIB	Biogen Inc.	46,536	$10,054,568
6	OGN	Organon & Co.	575,000	$7,785,500
7	ABBV	AbbVie Inc. This page	25,497	$6,416,065
8	AZN	Astrazeneca PLC	13,330	$2,527,634

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$6,416,065	25,497	-59.3%	Shares	Sole	2026-08-13
2026-03-31	$13,637,492	62,704	-10.7%	Shares	Sole	2026-05-13
2025-12-31	$16,047,081	70,231	-35.3%	Shares	Sole	2026-02-11
2025-09-30	$25,137,603	108,567	+41.3%	Shares	Sole	2025-11-12
2025-06-30	$14,258,214	76,814	+1280133.3%	Shares	Sole	2025-08-12
2025-03-31	$1	6	0.0%	Shares	Sole	2025-05-07
2024-12-31	$1,066	6	0.0%	Shares	Sole	2025-04-02
2024-09-30	$1	6	-100.0%	Shares	Sole	2024-11-04
2023-03-31	$8,560,878	53,717	-16.7%	Shares	Sole	2023-05-08
2022-12-31	$10,426,430	64,516	-4.7%	Shares	Sole	2023-02-13
2022-09-30	$9,086,688	67,705	+1.0%	Shares	Sole	2022-11-09
2022-06-30	$10,266,314	67,030	+232.4%	Shares	Sole	2022-08-08
2022-03-31	$3,268,948	20,165	—	Shares	Sole	2022-05-11
No filing history on record for this holder in this stock.